Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.
Sonia PernasJennifer L GuerrieroSergey NaumenkoShom GoelMeredith M ReganJiani HuBeth T HarrisonFilipa LynceNancy U LinAnn PartridgeAki MorikawaJohn HutchinsonElizabeth A MittendorfArtem SokolovBeth OvermoyerPublished in: Therapeutic advances in medical oncology (2022)
ClinicalTrials.gov identifier: NCT01796197 (https://clinicaltrials.gov/ct2/show/NCT01796197); registered on February 21, 2013.